APCER Life Sciences

What APCER Life Sciences does

APCER Life Sciences is a UK-headquartered private contract research organization founded in 2007 as part of the APC Group, providing pharmacovigilance, medical information, regulatory affairs, medical writing, and quality assurance services to pharmaceutical, biotechnology, generic, and medical device companies across 100+ markets. The company processes 270,000+ ICSR cases annually at 99.9% health authority compliance, delivers 750+ aggregate reports per year for 40+ clients, evaluates signals across 500+ molecules, manages 40,000+ medical inquiries in 30+ languages, and has authored 1,600+ Risk Management Plans over the past decade, supported by a 100% healthcare professional delivery team with a 15% physician pool.

The company's core technology platform is ANSA, a proprietary ecosystem of four AI-powered products — SafetyCore (AI-powered safety database), SafetyFlow (AI-driven case intake and management), LitSense (AI-powered literature screening), and REMSConnect (REMS/aRMM web application) — built by pharmacovigilance practitioners for regulated environments. These are integrated with hosted enterprise safety databases from Oracle (ARGUS 25.1) and ARIS (LSMV/LSRA), along with Ring Central cloud telephony and the IRMS medical information database validated to 21 CFR Part 11 and GAMP 5.

APCER operates on a hybrid revenue model combining professional services contracts (project-based and retainers across PV, medical information, regulatory, writing, and QA) with subscription-based SaaS deployment of its ANSA technology platform. Go-to-market is entirely direct enterprise sales targeting pharma/biotech/medical device decision-makers, with no channel partners. The company maintains 501-1000 employees across offices in London (global headquarters), Jersey City (North America regional HQ), Aachen (EU presence), and two India operations centers in Noida and Ahmedabad, and is privately held by the APC Group with no public equity listing or disclosed external institutional investors.

Name

APCER Life Sciences

Legal name

APCER Life Sciences Ltd.

Website

https://apcerls.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

501–1,000 employees

Short description

APCER Life Sciences is a UK-based private CRO providing pharmacovigilance, medical information, regulatory affairs, medical writing, and quality assurance services to pharmaceutical, biotech, and medical device companies globally, powered by its proprietary ANSA AI technology ecosystem.

Ownership category

akta.pro rank

Product category

Pharmacovigilance and Drug Safety Services

NAICS

Other Scientific and Technical Consulting Services (54169), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Pharmacovigilance, Drug Safety & Risk Management FSP (HLAGAOAF)

akta.pro secondary industries

Safety Database Operations & Hosting (Argus/ARISg/Oracle) (HLAGALAB), Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL), Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL), PV Regulatory Submissions & Safety Reporting (E2B/CIOMS/Expedited) (HLAGALAJ)

Keywords

• Pharmacovigilance services
• Drug safety reporting
• Regulatory affairs consulting
• Medical information services
• Clinical safety monitoring

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmacovigilance Services: Comprehensive pharmacovigilance services including ICSR case processing, literature surveillance, aggregate report management, signal management, risk management, QPPV services, and PSMF management. Delivered by 100% healthcare professional teams with physician oversight. Revenue generated through contractual service agreements with pharmaceutical and biotech companies.
2. Medical Information Services: Medical inquiry management including adverse event reporting, product complaint handling, and specialized REMS contact center services. 24/7/365 operations from US and India centers supporting 30+ languages. Revenue generated through service contracts.
3. Regulatory Affairs Services: End-to-end regulatory solutions including dossier preparation, eCTD publishing and submissions portal management, labeling, lifecycle management, and US agent services. Strategic consulting and scientific advice support. Revenue through project-based and retainer service agreements.
4. Medical Writing Services: Clinical, regulatory, and scientific writing services covering entire product lifecycle. Includes regulatory medical writing support with eCTD modules, manuscripts, slide sets, posters, and quality control review. Revenue through project-based professional services.
5. Quality Assurance Services: Comprehensive QA oversight including risk-based audit programs, inspection readiness, CAPA management, and quality management systems. Services support pharmaceutical, biotech and medical device companies across drug development lifecycle.
6. Technology Solutions: SaaS deployment of validated safety databases and proprietary AI-powered technology platforms. ANSA ecosystem solutions provided as hosted services with validation documentation and audit-ready evidence. Revenue through subscription-based technology services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

APCER Life Sciences provides end-to-end drug safety and pharmacovigilance services to pharmaceutical, biotechnology, and medical device companies, including ICSR case processing, literature surveillance, aggregate report management, signal management, risk management, REMS program execution, QPPV services, medical information management, regulatory affairs, medical writing, and quality assurance. Services are powered by the proprietary ANSA AI technology ecosystem and delivered by 100% healthcare professional teams, processing 270,000+ ICSR cases and 750+ aggregate reports annually for 90+ customers across 100+ markets.

Product overview

APCER Life Sciences offers a unified technology ecosystem (ANSA) with four proprietary AI-powered products (SafetyCore, SafetyFlow, LitSense, REMSConnect) integrated with Oracle ARGUS and ARIS safety databases. The platform is complemented by comprehensive services including ICSR Case Processing (270,000+ cases/year), Literature Search, Aggregate Report Management (750+ reports/year), Signal Management (500+ molecules/year), Risk Management, REMS/aRMM, QPPV, PSMF, Integrated PV/MI, Medical Information, Regulatory Affairs, Medical Writing, and Quality Assurance — all delivered by 100% healthcare professional teams with a 15% physician pool.

Differentiator

Problem solved

Functional benefit

Products and services

• ANSA PV SafetyCore Proprietary next-generation AI-powered global safety database that integrates case intake, processing, and literature workflows into a single unified platform, designed for fast adoption and full interoperability with existing safety databases. Used by pharmaceutical and biotech companies for global safety reporting.
• ANSA PV SafetyFlow Proprietary AI-powered case intake and case management tool that automates intake from structured and unstructured sources, producing E2B(R3) compliant output with human-in-the-loop review, validation, and physician oversight. Already processing thousands of cases in production.
• ANSA PV LitSense Proprietary end-to-end AI-powered tool for literature screening and review, enabling accelerated, traceable screening that reduces effort while preserving full scientific oversight with AI-assisted classification and bulk ingestion capabilities.
• ANSA PV REMSConnect Proprietary customizable and configurable web application for REMS and aRMM program execution, providing a single platform for stakeholder management, training, real-time dashboards, compliance tracking, AI-enabled fax processing, and configurable workflows. Aligned with HL7 FHIR CodeX standards.
• ICSR Case Processing Services End-to-end ICSR (Individual Case Safety Report) management services powered by healthcare professionals, processing 270,000+ cases annually with greater than 99.9% health authority compliance, reporting into 100+ countries. For pharmaceutical and biotech companies requiring global safety reporting.
• Literature Search Services Expert literature surveillance services supported by ANSA PV LitSense AI technology, covering global and local literature screening across multiple therapeutic areas with AI-assisted classification. For pharmaceutical companies monitoring global medical literature for safety signals.
• Aggregate Report Management Services Comprehensive aggregate report management including PSUR, PBRER, DSUR, PADER, and other global report types, delivered by 50+ specialists with over 30% physicians, producing 750+ reports annually for 40+ global life sciences companies.
• Signal Management Services Signal detection and management services combining advanced technology with clinical expertise, evaluating signals across 500+ molecules annually with physician-led evaluation. For pharmaceutical and biotech companies managing drug safety surveillance.
• Risk Management Services Comprehensive risk management solutions including authoring and updating Risk Management Plans (RMPs), with 1,600+ RMPs authored over the last decade, supported by ANSA PV REMSConnect technology.
• REMS/aRMM Services Strategic design and execution of REMS (Risk Evaluation and Mitigation Strategies) and aRMM (additional Risk Minimization Measures) programs combining regulatory expertise, healthcare professional-led operations, and ANSA PV REMSConnect technology.
• QPPV Services Qualified Person for Pharmacovigilance services across EU, UK, and Rest of World markets with on-ground understanding across 120+ countries and flawless inspection history. Provides local QPPV representation for marketing authorization holders.
• PSMF Management Services Pharmacovigilance System Master File management services including creation, maintenance, and periodic updates to ensure inspection readiness and regulatory compliance for marketing authorization holders.
• Integrated PV/MI Services Unified pharmacovigilance and medical information model delivering consistent, expert-led safety communication 24/7 with integrated workflows combining case intake, medical inquiries, and adverse event reporting.
• Medical Information Services Global medical information services including inquiry management, adverse event reporting, and product complaint handling, supporting 50+ countries in 30+ languages with 40,000+ inquiries managed annually for pharmaceutical and biotech customers.
• Integrated Response Center 24/7/365 medical information response center from US and India centers supporting 30+ languages with full regulatory and GDPR-aligned processes. Powered by Ring Central cloud telephony and IRMS medical information database validated to 21 CFR Part 11 and GAMP 5.
• Specialized REMS Contact Center Dedicated REMS contact center staffed by trained healthcare professionals providing 24/7 support for certification, enrollment, and program-related inquiries. Achieves greater than 98% SLA performance with abandonment rate below 3%.
• Regulatory Affairs Services End-to-end regulatory solutions including eCTD publishing, dossier preparation, submission management, labeling, lifecycle management, and regulatory intelligence for pharmaceutical, biotech, and medical device companies across global markets.
• Medical Writing Services Clinical, regulatory, and scientific medical writing services across 30+ therapeutic areas including clinical writing, regulatory writing, scientific communication, and medical devices documentation for pharma and biotech customers.
• Quality Assurance Services Comprehensive QA oversight including risk-based audit programs, inspection readiness, CAPA management, and quality management system setup aligned with GVP/GCP requirements for pharmaceutical, biotech, and medical device companies.

Quantifiable outcome

• 270,000+ cases processed annually with 99.9% health authority compliance worldwide
• +7 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability5 records

Feature8 records

Partnerships

Three partnerships are on record, tiered core and supporting.

• OraclecoreTechnology or IntegrationOracle ARGUS 25.1 (including Analytics and Insights) is hosted and deployed in APCER's secure multi-tenant SaaS environment. APCER provides enterprise safety database services using Oracle technology, enabling rapid onboarding, seamless upgrades, and continuous regulatory alignment for clients.
• ARIScoreTechnology or IntegrationAPCER deploys LSMV/LSRA from ARIS as part of their safety database ecosystem. ARIS safety database complements Oracle ARGUS for comprehensive safety reporting capabilities.
• Ring CentralsupportingTechnology or IntegrationRing Central's cloud telephony system is integrated with APCER's medical information response center operations, supporting 24/7/365 global operations for medical inquiry management and REMS contact center services.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• IQVIA: The world's largest CRO with comprehensive pharmacovigilance, regulatory affairs, and technology offerings. Competes with APCER for enterprise pharma PV outsourcing contracts but serves a much broader clinical-to-commercial scope.
• Parexel International: Global CRO with established pharmacovigilance and regulatory services. Targets similar large pharma and biotech customers for safety case processing, aggregate reporting, and regulatory submissions.
• ICON plc: Major clinical CRO that has expanded into post-approval pharmacovigilance and regulatory services through acquisitions, competing for similar enterprise safety database and case processing engagements.
• Labcorp Drug Development (Covance): Large CRO with extensive post-market pharmacovigilance and regulatory services through Labcorp Drug Development. Competes for similar safety and regulatory outsourcing contracts with major pharma.

Direct peers

• PrimeVigilance: Specialist pharmacovigilance CRO offering ICSR processing, aggregate reporting, signal management, and QPPV services. Closest direct peer to APCER given similar PV-only focus and mid-size scale.
• Ergomed (now Asahi Kasei): PV and pharmacovigilance specialist CRO acquired by Asahi Kasei. Direct competitor offering similar case processing, signal detection, and risk management services to pharma and biotech.
• ProPharma Group: Compliance and regulatory consulting firm providing pharmacovigilance, quality assurance, and regulatory affairs services. Directly comparable mid-market peer in the life sciences consulting space.
• PharmaLex: Specialized regulatory, pharmacovigilance, and quality consulting firm (now part of Cencora). Competes directly with APCER in regulatory affairs, PV, and medical writing for pharma and biotech.
• Worldwide Clinical Trials: Mid-size CRO with strong PV, regulatory, and medical writing capabilities. Comparable in scale and service mix to APCER, targeting similar biotech and specialty pharma segments.
• Arriello: European-headquartered specialist PV and regulatory services provider. Competes with APCER in drug safety case processing, medical information, and regulatory consulting for European pharma clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/apcerls
• Facebookfacebook.com/apcerlifesciences
• LinkedInlinkedin.com/company/apcer-life-sciences

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about APCER Life Sciences